Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 7,500 full-time employees. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. The company also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
최신 재무제표(Form-10K)에 따르면, Merit Medical Systems Inc의 총 자산은 $0이며, 순손실입니다.
MMSI의 주요 재무 비율은 무엇인가요?
Merit Medical Systems Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Merit Medical Systems Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Merit Medical Systems Inc 주요 수익원은 Cardiovascular이며, 최신 수익 발표에서 수익은 700,613,000입니다. 지역별로는 United States이 Merit Medical Systems Inc의 주요 시장이며, 수익은 909,466,000입니다.
Merit Medical Systems Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Merit Medical Systems Inc의 순손실은 $0입니다.